Literature DB >> 19945236

Treatment options for threatened miscarriage.

N S Qureshi1.   

Abstract

Threatened miscarriage, as demonstrated by vaginal bleeding with or without abdominal cramps, is a common complication of pregnancy. It occurs in about 20% of recognised pregnancies. Risk of miscarriage is increased in older women and those with a history of miscarriage. Low serum levels of progesterone or human chorionic gonadotrophin (hCG) are a risk factor for miscarriage. Other risk factors include heavy bleeding, early gestational age and an empty gestational sac of >15-17 mm diameter. Clinical history and examination, maternal serum biochemistry and ultrasound findings provide valuable information about the prognosis and are important to establish in order to determine potential treatment options. Although bed rest is the most common choice of treatment, there is little evidence of its value. Other options include luteal support with progesterone, dydrogesterone or hCG. There is some evidence from clinical studies indicating that progesterone or dydrogesterone may reduce the rate of miscarriage, although further data from double-blind, randomised-controlled trials are necessary to confirm efficacy. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19945236     DOI: 10.1016/j.maturitas.2009.10.010

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  9 in total

1.  Miscarriage Occurrence and Prevention Efforts by Disability Status and Type in the United States.

Authors:  Mekhala V Dissanayake; Blair G Darney; Aaron B Caughey; Willi Horner-Johnson
Journal:  J Womens Health (Larchmt)       Date:  2019-11-21       Impact factor: 2.681

Review 2.  Extragonadal actions of chorionic gonadotropin.

Authors:  Prajna Banerjee; Asgerally T Fazleabas
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

3.  Live birth rates and safety profile using dydrogesterone for luteal phase support in assisted reproductive techniques.

Authors:  Ravichandran Nadarajah; Hemashree Rajesh; Ker Yi Wong; Fazlin Faisal; Su Ling Yu
Journal:  Singapore Med J       Date:  2016-04-19       Impact factor: 1.858

4.  Oral versus Vaginal Micronized Progesterone for the Treatment of Threatened Miscarriage.

Authors:  Rashida Parveen; Mehnaz Khakwani; Sobia Tabassum; Sajjad Masood
Journal:  Pak J Med Sci       Date:  2021 May-Jun       Impact factor: 1.088

5.  Comparison of the efficacy and safety of phloroglucinol and magnesium sulfate in the treatment of threatened abortion: A meta-analysis of randomized controlled trials.

Authors:  Shaofei Yuan; Fengli Gao; Zhong Xin; Haijun Guo; Suqin Shi; Lei Shi; Xia Yang; Jingzhi Guan
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.889

6.  Efficacy and safety of traditional Chinese herbal medicine in the treatment of threatened abortion: A protocol for systematic review and meta-analysis.

Authors:  Pengfei Zeng; Hang Zhou; Pei Guo; Wanting Xia; Jinzhu Huang; Qian Zeng
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

7.  The effect of progesterone suppositories on threatened abortion: a randomized clinical trial.

Authors:  Fakhrolmolouk Yassaee; Reza Shekarriz-Foumani; Shabnam Afsari; Masoumeh Fallahian
Journal:  J Reprod Infertil       Date:  2014-07

8.  Comparison of Risk of Preterm Labor between Vaginal Progesterone and17-Alpha-Hydroxy-Progesterone Caproate in Women with Threatened Abortion: A Randomized Clinical Trial.

Authors:  Abootaleb Beigi; Arezoo Esmailzadeh; Reyhane Pirjani
Journal:  Int J Fertil Steril       Date:  2016-06-01

9.  Relationship between threatened miscarriage and gestational diabetes mellitus.

Authors:  Hee Joong Lee; Errol Norwitz; Banghyun Lee
Journal:  BMC Pregnancy Childbirth       Date:  2018-08-06       Impact factor: 3.007

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.